490 results on '"Cisternino, Salvatore"'
Search Results
2. Duloxetine enhances PAX6 expression and suppresses innate immune responses in murine LPS-induced corneal inflammation
3. Mechanistic insights into P-glycoprotein ligand transport and inhibition revealed by enhanced molecular dynamics simulations
4. Safety of Obinutuzumab in Children With Autoimmune Encephalitis and Early B-Cell Repopulation on Rituximab
5. Place de l’entretien pharmaceutique dans la prise en charge de patients transplantés rénaux éligibles à un traitement prophylactique à base d’immunoglobuline anti-SARS-CoV-2
6. Brain PET imaging using 11C-flumazenil and 11C-buprenorphine does not support the hypothesis of a mutual interaction between buprenorphine and benzodiazepines at the neuroreceptor level
7. Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome
8. In mice and humans, brain microvascular contractility matures postnatally
9. Hydroxychloroquine sulfate: A novel treatment for lipin-1 deficiency?
10. Formulation and Stability of a 1% Clarithromycin-Based Topical Skin Cream: A New Option to Treat Buruli Ulcers?
11. Ruxolitinib photodegradation mechanisms by theoretical and experimental chemistry
12. Brain PET imaging using 11 C-flumazenil and 11 C-buprenorphine does not support the hypothesis of a mutual interaction between buprenorphine and benzodiazepines at the neuroreceptor level.
13. Retinal and choroidal cancers: Blood-retinal barriers considerations in ocular chemotherapy
14. Contributors
15. The Pharmacokinetics of Lithium
16. Safety of intrathecal route: focus to methylprednisolone acetate (Depo-Medrol) use
17. Self-application of aminoglycoside-based creams to treat cutaneous leishmaniasis in travelers
18. A major role for CD4+ T cells in driving cytokine release syndrome during CAR T cell therapy
19. Imaging Probes and Modalities for the Study of Solute Carrier O (SLCO)-Transport Function In Vivo
20. Evaluation of TSPO PET imaging, a marker of glial activation, to study the neuroimmune footprints of morphine exposure and withdrawal
21. Maternal ABVD chemotherapy for Hodgkin lymphoma in a dichorionic diamniotic pregnancy: a case report
22. Improvement of epidermal covering on AEC patients with severe skin erosions by PRIMA-1MET/APR-246
23. Intravenous infusion for the controlled exposure to the dual ABCB1 and ABCG2 inhibitor elacridar in nonhuman primates
24. Functional and targeted proteomics characterization of a human primary endothelial cell model of the blood-brain barrier (BBB) for drug permeability studies
25. Pharmaceutical Oral Formulation of Methionine as a Pediatric Treatment in Inherited Metabolic Disease
26. Immunoregulation at the gliovascular unit in the healthy brain: A focus on Connexin 43
27. Effect of Subchronic Intravenous Morphine Infusion and Naloxone-Precipitated Morphine Withdrawal on P-gp and Bcrp at the Rat Blood–Brain Barrier
28. Dissimilar Effect of P‑Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Distribution of Erlotinib to the Retina and Brain in Humans and Mice.
29. Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome
30. Indications and Safety of Rituximab in Pediatric Neurology: A 10-Year Retrospective Study
31. Setting up of a hospital Covid‐19 vaccination center: A descriptive study
32. In mice and humans, brain microvascular contractility matures postnatally
33. Extensive dermatophytosis caused by terbinafine-resistant Trichophyton indotineae, successfully treated with topical voriconazole
34. TSPO PET Imaging as a Potent Non-Invasive Biomarker for Diffuse Intrinsic Pontine Glioma in a Patient-Derived Orthotopic Rat Model
35. Isolation and differential transcriptome of vascular smooth muscle cells and mid-capillary pericytes from the rat brain
36. Subcontracting sterile pediatric and adult chemotherapy preparations activity: A global risk analysis
37. Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease
38. [11C]befloxatone brain kinetics is not influenced by Bcrp function at the blood–brain barrier: A PET study using Bcrp TGEM knockout rats
39. Gender and strain contributions to the variability of buprenorphine-related respiratory toxicity in mice
40. Diphenhydramine as a selective probe to study H+-antiporter function at the blood–brain barrier: Application to [11C]diphenhydramine positron emission tomography imaging
41. Influence of P-Glycoprotein Inhibition or Deficiency at the Blood–Brain Barrier on 18F-2-Fluoro-2-Deoxy-d-glucose (18F-FDG) Brain Kinetics
42. In mice and humans, brain microvascular contractility matures postnatally Brain microvessel post-natal maturation
43. Massive tramadol ingestion resulting in fatal brain injury – a pharmacokinetic study with discussion on the involved mechanisms of toxicity
44. Treatment of Painful Palmoplantar Keratoderma Related to Pachyonychia Congenita Using EGFR Inhibitors
45. The Pharmacokinetics of Lithium
46. Stability and Formulation of Erlotinib in Skin Creams
47. Pharmacophore-Based Discovery of Substrates of a Novel Drug/Proton-Antiporter in the Human Brain Endothelial hCMEC/D3 Cell Line
48. In Mice and Humans, Brain Vascular Barrier Homeostasis and Contractility Are Acquired Postnatally
49. Impact of P-glycoprotein at the blood-brain barrier on the uptake of heroin and its main metabolites: behavioral effects and consequences on the transcriptional responses and reinforcing properties
50. Validation of a simple HPLC-UV method for rifampicin determination in plasma: Application to the study of rifampicin arteriovenous concentration gradient
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.